Publicacions en què col·labora amb Mónica Vicente Pascual (11)

2023

  1. SLNs como sistemas de transfección para el desarrollo deterapias CAR-T ex vivo

    XVI Congreso SEFIG ( 16. 2023. Madrid): Libro de comunicaciones

2021

  1. Mrna-based nanomedicinal products to address corneal inflammation by interleukin-10 supplementation

    Pharmaceutics, Vol. 13, Núm. 9

  2. α-Galactosidase A Augmentation by Non-Viral Gene Therapy: Evaluation in Fabry Disease Mice

    Pharmaceutics, Vol. 13, Núm. 6

2020

  1. Gene Therapy

    Advances in Biochemical Engineering/Biotechnology (Springer), pp. 321-368

  2. Nanomedicines to deliver mRNA: State of the art and future perspectives

    Nanomaterials, Vol. 10, Núm. 2

  3. Nucleic Acid Delivery by Solid Lipid Nanoparticles Containing Switchable Lipids: Plasmid DNA vs. Messenger RNA

    Molecules (Basel, Switzerland), Vol. 25, Núm. 24

  4. Topical administration of sln-based gene therapy for the treatment of corneal inflammation by de novo il-10 production

    Pharmaceutics, Vol. 12, Núm. 6, pp. 1-23

2019

  1. Gene-terapia: ikuspegi terapeutiko berria begietako gaitzen tratamenduan

    Ekaia: Euskal Herriko Unibertsitateko zientzi eta teknologi aldizkaria, Núm. 36, pp. 31-48

  2. MMP-9 downregulation with lipid nanoparticles for inhibiting corneal neovascularization by gene silencing

    Nanomaterials, Vol. 9, Núm. 4

2018

  1. Gene delivery in the cornea: In vitro & ex vivo evaluation of solid lipid nanoparticle-based vectors

    Nanomedicine, Vol. 13, Núm. 15, pp. 1847-1864

  2. Targeting corneal inflammation by gene therapy: Emerging strategies for keratitis

    Experimental Eye Research, Vol. 176, pp. 130-140